Benelux Supraglottic Devices Market Outlook (2022-2033)

Increasing Shift Toward Minimally Invasive Airway Solutions

The Benelux supraglottic devices market is increasingly driven by a shift toward minimally invasive airway solutions as healthcare providers aim to optimize patient safety and procedural efficiency. Supraglottic airway devices (SGAs) are gaining preference because they simplify airway management, allowing clinicians to secure the airway quickly without requiring extensive intubation expertise. In high-traffic surgical units and emergency care settings, the ability to perform rapid, reliable airway management is essential, making SGAs a practical choice for both routine and urgent interventions.

The shift is further supported by the growing emphasis on reducing patient recovery times and minimizing procedure-related complications. Minimally invasive techniques, including SGAs, allow faster airway control and reduced anesthesia duration, which improves patient throughput and overall operational efficiency. Hospitals increasingly favor devices that balance ease of use with clinical effectiveness, particularly in multi-disciplinary surgical environments where standardizing airway protocols enhances safety and workflow.

Cost-effectiveness and hygiene considerations also play a significant role in this transition. Single-use SGAs reduce the need for extensive sterilization and mitigate infection risks, aligning with the strict safety and regulatory standards typical of healthcare systems in the Benelux region. Combined with ergonomic designs and improved sealing mechanisms, these devices are becoming central to modern airway management strategies, supporting a continued trend toward minimally invasive solutions.

Expanding Use of Training Through Simulation Technologies

The adoption of training through simulation technologies is accelerating in the Benelux supraglottic devices market, reflecting a strong focus on skill development and clinical competence. Simulation-based programs provide healthcare professionals with opportunities to practice device insertion, troubleshoot complications, and refine procedural techniques in a controlled environment, reducing the risk of errors during actual patient care. This approach is particularly important for multidisciplinary teams working in surgical or emergency settings, where consistent proficiency across staff is critical.

Structured workshops and interactive training modules are increasingly integrated into professional development programs, combining theoretical instruction with hands-on practice. Simulation exercises allow clinicians to gain experience with multiple types of SGAs and patient scenarios, ensuring readiness for diverse clinical situations. By reinforcing standardized airway management protocols, these programs help maintain high levels of patient safety and procedural reliability throughout hospital systems.

Integration of simulation technologies into ongoing medical education is enhancing the long-term adoption of supraglottic devices. Even facilities with limited resources are implementing low-cost simulation models or peer-led training sessions to build staff competency. Repeated practice in realistic scenarios strengthens confidence and technique, driving consistent use of SGAs in clinical workflows. As a result, training through simulation is increasingly recognized as a cornerstone of safe, efficient airway management in the Benelux region.

The "Benelux Supraglottic Devices Market Size and Forecast (2022–2033)" report provides a detailed analysis of the market covering below areas:

• Benelux Supraglottic Devices market size and forecast at regional and country levels for all market segments covered under the scope
• Benelux Supraglottic Devices market trends, as well as drivers, restraints, and opportunities
• Benelux Supraglottic Devices market analysis covering key trends, regional framework, major players, regulations, and recent developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the Benelux Supraglottic Devices market
• Detailed company profiles, including SWOT analysis

The geographical scope of the Benelux Supraglottic Devices market report is divided into: Belgium, the Netherlands, and Luxembourg. The Netherlands held the largest share in 2025.

The Netherlands dominates the Benelux supraglottic devices market due to the presence of advanced healthcare facilities and a proactive stance toward innovations in medical practice. The Dutch hospitals and clinics are known to have a systemized approach to managing patients' airways and integrating supraglottic devices into anesthesia and emergency procedures in particular. Patient safety and the effectiveness of the procedure become primary concerns in the Netherlands. Consequently, supraglottic devices become an efficient means for dealing with both elective and emergency cases.

Professional education is crucial for achieving supremacy in the Benelux market. The training of anesthesiologists, emergency specialists, and critical care specialists is carried out on a regular basis in order for doctors to be familiar with various means of managing patients' airways. Moreover, collaboration and networking by academic medical centers and community hospitals foster the exchange of information and practices, making it possible for the integration of supraglottic devices within clinical guidelines to occur at a much faster pace. There is a careful review of more modern types of equipment, weighing the aspects of innovation and cost-effectiveness. Although budgetary limitations and cautious clinical practices might slow down the process in some hospitals, the Netherlands is leading the way when compared to other countries in the Benelux region.

• The report includes qualitative and quantitative data in the Benelux Supraglottic Devices market across product type, usage type, application, patient type, end user, and geography.
• The report starts with the key takeaways (chapter 2), highlighting the key trends and outlook of the Benelux Supraglottic Devices market.
• Chapter 3 focuses on the research methodology of the study.
• Chapter 4 includes ecosystem analysis.
• Chapter 5 highlights the major industry dynamics in the Benelux Supraglottic Devices market, including factors that are driving the market, prevailing deterrents, potential opportunities, as well as future trends. Impact analysis of these drivers and restraints is also covered in this section.
• Chapter 6 discusses the Benelux Supraglottic Devices market scenario, in terms of historical market revenues, and forecast till the year 2033.
• Chapters 7 to 12 cover the Benelux Supraglottic Devices market segments by product type, usage type, application, patient type, end user, and geography across Belgium, the Netherlands, and Luxembourg. They cover the market revenue, forecast, and factors driving the market.
• Chapter 13 describes the competitive analysis along with the heat map analysis for the key players operating in the market.
• Chapter 14 describes the industry landscape analysis. It provides detailed descriptions of business activities such as market initiatives, new developments, mergers, and joint ventures globally, along with a competitive landscape.
• Chapter 15 provides detailed profiles of the major companies operating in the Benelux Supraglottic Devices market. Companies have been profiled on the basis of their key facts, business descriptions, products, financial overview, SWOT analysis, and key developments.
• Chapter 16, i.e., the appendix, is inclusive of a brief overview of the company, list of abbreviations, and disclaimer.

The Benelux Supraglottic Devices market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the Benelux Supraglottic Devices market are:

• In December 2025, Ambu A/S announced that it had launched its new Ambu SureSight Connect video laryngoscopy solution, an advanced airway visualization system designed to improve intubation and airway management procedures, with phased launches in additional markets throughout 2025 beyond the U.S., including Europe (which covers Benelux). This expands Ambu’s airway management portfolio that includes airway device solutions used alongside supraglottic airway devices.
• In July 2023, Ambu A/S announced that it had launched its full one‑lung ventilation portfolio within Europe, marking the commercial rollout of the Ambu VivaSight 2 SLT (single‑lumen tube) and complementary respiratory management solutions across European markets. Although focused on one‑lung ventilation, this reflects ongoing product expansion in airway management, which impacts clinical workflows that include supraglottic devices.